Literature DB >> 33778781

Protocol for in vitro skin fibrosis model to screen the biological effects of antifibrotic compounds.

Amir M Alsharabasy1, Abhay Pandit1.   

Abstract

Controversies remain over the standard procedures for the modeling of skin fibrosis and its use in in vitro testing of different drugs. Here, we report a reproducible protocol for producing a skin fibrosis model using human dermal fibroblasts seeded in collagen hydrogel. Detailed procedures for the fabrication of cell/hydrogel constructs, fibrosis induction, protein extraction for western blotting analysis are presented along with how this model can be employed for investigating the possible anti-fibrotic functions of certain chemical compounds.
© 2021 The Author(s).

Entities:  

Keywords:  Biophysics; Cell biology; Tissue engineering

Mesh:

Substances:

Year:  2021        PMID: 33778781      PMCID: PMC7982747          DOI: 10.1016/j.xpro.2021.100387

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


  8 in total

1.  The myofibroblast markers α-SM actin and β-actin are differentially expressed in 2 and 3-D culture models of fibrotic and normal skin.

Authors:  M C Vozenin; J L Lefaix; R Ridi; D S Biard; F Daburon; M Martin
Journal:  Cytotechnology       Date:  1998-01       Impact factor: 2.058

2.  Western blot analysis of cells encapsulated in self-assembling peptide hydrogels.

Authors:  Kyle A Burgess; Aline F Miller; Delvac Oceandy; Alberto Saiani
Journal:  Biotechniques       Date:  2017-12-01       Impact factor: 1.993

3.  The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts.

Authors:  P D Arora; N Narani; C A McCulloch
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

4.  Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential.

Authors:  Yuval Rinkevich; Graham G Walmsley; Michael S Hu; Zeshaan N Maan; Aaron M Newman; Micha Drukker; Michael Januszyk; Geoffrey W Krampitz; Geoffrey C Gurtner; H Peter Lorenz; Irving L Weissman; Michael T Longaker
Journal:  Science       Date:  2015-04-17       Impact factor: 47.728

5.  Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition.

Authors:  Tamara Delaine; Patrick Collins; Alison MacKinnon; G Sharma; John Stegmayr; Vishal K Rajput; Santanu Mandal; Ian Cumpstey; Amaia Larumbe; Bader A Salameh; Barbro Kahl-Knutsson; Hilde van Hattum; Monique van Scherpenzeel; Roland J Pieters; Tariq Sethi; Hans Schambye; Stina Oredsson; Hakon Leffler; Helen Blanchard; Ulf J Nilsson
Journal:  Chembiochem       Date:  2016-08-12       Impact factor: 3.164

6.  Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.

Authors:  Alison C Mackinnon; Michael A Gibbons; Sarah L Farnworth; Hakon Leffler; Ulf J Nilsson; Tamara Delaine; A John Simpson; Stuart J Forbes; Nik Hirani; Jack Gauldie; Tariq Sethi
Journal:  Am J Respir Crit Care Med       Date:  2011-11-17       Impact factor: 30.528

Review 7.  The myofibroblast in wound healing and fibrosis: answered and unanswered questions.

Authors:  Marie-Luce Bochaton-Piallat; Giulio Gabbiani; Boris Hinz
Journal:  F1000Res       Date:  2016-04-26

8.  Peptide hydrogelation and cell encapsulation for 3D culture of MCF-7 breast cancer cells.

Authors:  Hongzhou Huang; Ying Ding; Xiuzhi S Sun; Thu A Nguyen
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.